Castle Biosciences Inc (CSTL) KPIs and segments
Close on Nov 17, 2026Market cap $1.01BP/E –Yield 0.00%
KPIs & segments
Operating metrics and segments that drive Castle Biosciences's business
Castle Biosciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-Dermatologic($M) | 54.8 | 42.6 | 38.4 | 34.5 | 29.9 | 25.0 | 22.5 | 20.7 | 18.2 | 13.6 | 12.8 | 10.3 | |
Dermatologic($M) | 48.7 | 41.1 | 48.6 | 48.5 | 56.3 | 63.0 | 63.8 | 65.1 | 68.8 | 59.3 | 53.3 | 51.2 | |
1 metric has no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-07-30.
See a number that looks wrong?